Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Reliq Health Technologies Inc V.RHT.H

Alternate Symbol(s):  RQHTF

Reliq Health Technologies Inc. is a global healthcare technology company that specializes in developing virtual care solutions for the healthcare market. The Company’s iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent hospital readmissions and ER visits. The iUGO Care platform integrates wearables, sensors, voice technology and mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. The iUGO Care platform provides services, such as remote patient monitoring, chronic care management, principal care management, behavioral health integration, telemedicine, transitional care management, wound care, and others.


TSXV:RHT.H - Post by User

Comment by lscfaon Apr 21, 2021 1:49pm
110 Views
Post# 33038094

RE:RE:RE:RE:RE:RE:RE:RE:RHT ANNOUNCE 2 NEW CONTRACTS WITH US NEPHROLOGY CLINICS

RE:RE:RE:RE:RE:RE:RE:RE:RHT ANNOUNCE 2 NEW CONTRACTS WITH US NEPHROLOGY CLINICS

 

$mil cdn.

2022 est.

Starting patients

41,667

Ending patients

65,000

Ave patients

53,333

Revenue @ $50/month

32.0

Gross margin

75%

Gross profit

24.0

Cash Overhead 

9.6

Op inc (ebitda)

14.4

ebitda margin

45%

Diluted shs 

180

ebitda/sh

$0.080

Multiple

12

Sh value 

$0.960

 





jtmoney wrote: So then we're trading at roughly 9x this year's revenue and 3x next year's revenue. Assuming they deliver on the numbers. 

 

<< Previous
Bullboard Posts
Next >>